Stock Events

Stock Events

CRISPR Therapeutics (1CG.MU) Q3 2026 Earnings

10AugConfirmed

Q1 2026

Q2 2026

Next

-1.15

-1.1

-1.04

-0.98

Details

Expected EPS

-1.0343031663200002

Actual EPS

N/A

Surprise EPS

1.03

Surprise Percent

+100%

Description

CRISPR Therapeutics (1CG.MU) will report earnings of for Q3 2026 on August 10, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.